Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bahr

Showing results (111-120 of 144) with videos related to

Pageof 15
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2024
Implementation of Single High-dose Liposomal Amphotericin B Based Induction Therapy for Treatment of HIV-associated Cryptococcal Meningitis in Uganda: A Comparative Prospective Cohort StudyJane Gakuru, Enock Kagimu, Biyue Dai, et al.
Microbiology Spectrum|June 21, 2022
Diagnostic and Prognostic Value of Cerebrospinal Fluid Lactate and Glucose in HIV-Associated Tuberculosis MeningitisEdwin Nuwagira, Kathy Huppler Hullsiek, Samuel Jjunju, et al.
Open Forum Infectious Diseases|August 11, 2018
Detrimental Outcomes of Unmasking Cryptococcal Meningitis With Recent ART InitiationJoshua Rhein, Kathy H Hullsiek, Emily E Evans, et al.
AIDS (London, England)|April 23, 2025
Diagnostic accuracy of the re-engineered urinary FujiLAM2 assay amongst hospitalized adults with advanced HIV disease: a prospective cohort studyJayne Ellis, Biyue Dai, Mable Kabahubya, et al.
Medrxiv : the Preprint Server for Health Sciences|October 3, 2025
CSF Hypo-Inflammation Drives Mortality in HIV-Associated Tuberculous MeningitisAnna L Wilt, David B Meya, Fiona V Cresswell, et al.
The Lancet. Infectious Diseases|January 12, 2020
Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation studyFiona V Cresswell, Lillian Tugume, Nathan C Bahr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2024
Comparison of Early Fungicidal Activity and Mortality Between Daily Liposomal Amphotericin B and Daily Amphotericin B Deoxycholate for Cryptococcal MeningitisSarah Kimuda, Richard Kwizera, Biyue Dai, et al.
Open Forum Infectious Diseases|February 16, 2026
Prevalence of CSF HIV VIRAL Escape and Associations With Neurocognitive Outcomes Among HIV-Associated Meningitis Survivors: A Cohort StudyLaura Nsangi, Gila Hale, Biyue Dai, et al.
HIV Medicine|April 30, 2016
Prognostic implications of baseline anaemia and changes in haemoglobin concentrations with amphotericin B therapy for cryptococcal meningitisL Tugume, B M Morawski, M Abassi, et al.
Open Forum Infectious Diseases|March 19, 2026
Use of DOOR and Win-Ratio Analysis in a Secondary Evaluation of a Histoplasmosis Clinical TrialTarsila Vieceli, Biyue Dai, Diego R Falci, et al.
Pageof 15

Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2024
Implementation of Single High-dose Liposomal Amphotericin B Based Induction Therapy for Treatment of HIV-associated Cryptococcal Meningitis in Uganda: A Comparative Prospective Cohort StudyJane Gakuru, Enock Kagimu, Biyue Dai, et al.
Microbiology Spectrum|June 21, 2022
Diagnostic and Prognostic Value of Cerebrospinal Fluid Lactate and Glucose in HIV-Associated Tuberculosis MeningitisEdwin Nuwagira, Kathy Huppler Hullsiek, Samuel Jjunju, et al.
Open Forum Infectious Diseases|August 11, 2018
Detrimental Outcomes of Unmasking Cryptococcal Meningitis With Recent ART InitiationJoshua Rhein, Kathy H Hullsiek, Emily E Evans, et al.
AIDS (London, England)|April 23, 2025
Diagnostic accuracy of the re-engineered urinary FujiLAM2 assay amongst hospitalized adults with advanced HIV disease: a prospective cohort studyJayne Ellis, Biyue Dai, Mable Kabahubya, et al.
Medrxiv : the Preprint Server for Health Sciences|October 3, 2025
CSF Hypo-Inflammation Drives Mortality in HIV-Associated Tuberculous MeningitisAnna L Wilt, David B Meya, Fiona V Cresswell, et al.
The Lancet. Infectious Diseases|January 12, 2020
Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation studyFiona V Cresswell, Lillian Tugume, Nathan C Bahr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2024
Comparison of Early Fungicidal Activity and Mortality Between Daily Liposomal Amphotericin B and Daily Amphotericin B Deoxycholate for Cryptococcal MeningitisSarah Kimuda, Richard Kwizera, Biyue Dai, et al.
Open Forum Infectious Diseases|February 16, 2026
Prevalence of CSF HIV VIRAL Escape and Associations With Neurocognitive Outcomes Among HIV-Associated Meningitis Survivors: A Cohort StudyLaura Nsangi, Gila Hale, Biyue Dai, et al.
HIV Medicine|April 30, 2016
Prognostic implications of baseline anaemia and changes in haemoglobin concentrations with amphotericin B therapy for cryptococcal meningitisL Tugume, B M Morawski, M Abassi, et al.
Open Forum Infectious Diseases|March 19, 2026
Use of DOOR and Win-Ratio Analysis in a Secondary Evaluation of a Histoplasmosis Clinical TrialTarsila Vieceli, Biyue Dai, Diego R Falci, et al.
Pageof 15